← Open Payments lookup

MIRIAM MERNEIGH: Open Payments

NPI 1669028320 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,872 in 111 payments from 22 companies in 2025. Trend: 2023 $1,300 · 2024 $1,841 · 2025 $2,872

Food & beverage: $2,872
CompanyPaymentsAmount
GlaxoSmithKline, LLC.32$717
AstraZeneca Pharmaceuticals LP20$507
GENZYME CORPORATION8$339
Insmed, Inc.14$188
Verona Pharma, Inc.4$184
Avadel CNS Pharmaceuticals, LLC2$143
ANI Pharmaceuticals, Inc.3$139
Regeneron Healthcare Solutions, Inc.1$117
Viatris Specialty LLC5$107
Boehringer Ingelheim Pharmaceuticals, Inc.3$70

Products named: DUPIXENT, FASENRA, NUCALA, AREXVY, TRELEGY ELLIPTA, Ohtuvayre, Arikayce, LUMRYZ.

Industry payments across TX — which companies pay providers there.